Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,323,600
  • Shares Outstanding, K 259,269
  • Annual Sales, $ 4,163 M
  • Annual Income, $ 1,177 M
  • 60-Month Beta 1.32
  • Price/Sales 13.98
  • Price/Cash Flow 47.10
  • Price/Book 9.49

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 1.52
  • Number of Estimates 8
  • High Estimate 1.77
  • Low Estimate 1.29
  • Prior Year 0.85
  • Growth Rate Est. (year over year) +78.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
197.47 +17.45%
on 03/18/20
246.06 -5.75%
on 03/04/20
+7.89 (+3.52%)
since 02/28/20
3-Month
197.47 +17.45%
on 03/18/20
249.85 -7.18%
on 02/19/20
+10.95 (+4.96%)
since 12/27/19
52-Week
163.68 +41.69%
on 04/18/19
249.85 -7.18%
on 02/19/20
+47.97 (+26.08%)
since 03/29/19

Most Recent Stories

More News
Vertex to Halt Enrollment Due to Coronavirus, Keeps Sales View

Vertex (VRTX) announces plan to halt enrollment and delay study initiation amid coronavirus pandemic. However, it does not expect any supply chain disruption and maintains its business outlook for 2020....

PFE : 32.67 (+5.73%)
LLY : 138.44 (+3.23%)
BMY : 54.39 (+3.03%)
VRTX : 231.92 (+6.76%)
SmarTrend Watching for Potential Pullback in Shares of Vertex Pharm After 5.99% Gain

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $220.00 to a high of $233.77. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of...

VRTX : 231.92 (+6.76%)
Watch for Vertex Pharm to Potentially Pullback After Gaining 5.99% Yesterday

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $220.00 to a high of $233.77. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of...

VRTX : 231.92 (+6.76%)
Vertex Confirms Supply Chain Continuity and Business Outlook for Its Cystic Fibrosis Medicines and Provides Initial Update on Development Programs

Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today confirmed its 2020 business outlook and the continuity of the company's supply chain for its approved cystic fibrosis (CF) medicines and provided...

VRTX : 231.92 (+6.76%)
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $213.52, moving +1.46% from the previous trading session.

VRTX : 231.92 (+6.76%)
Sickle Cell Anemia Industry Outlook to 2026 Featuring CRISPR Therapeutics, Global Blood Therapeutics, Novartis, Pfizer, and Vertex Pharmaceuticals

The "Market Spotlight: Sickle Cell Anemia" report has been added to ResearchAndMarkets.com's offering.

CRSP : 44.29 (+5.91%)
GBT : 52.04 (+1.80%)
NVS : 81.90 (+3.30%)
VRTX : 231.92 (+6.76%)
Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals

Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals

VRTX : 231.92 (+6.76%)
FN : 52.72 (+9.06%)
DQ : 55.59 (+3.37%)
LITE : 74.09 (+5.84%)
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals

The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals

REGN : 473.00 (+5.22%)
MRNA : 30.48 (+1.43%)
VRTX : 231.92 (+6.76%)
CODX : 8.20 (-10.38%)
4 Top Biotech Stocks to Buy in the Time of Coronavirus

We have picked biotech companies that are widely expected to develop a vaccine for the coronavirus and fight off the worst stock market carnage since the 2008 financial crisis.

REGN : 473.00 (+5.22%)
MRNA : 30.48 (+1.43%)
VRTX : 231.92 (+6.76%)
CODX : 8.20 (-10.38%)
Pick These 4 Stocks With Impressive Interest Coverage Ratio

Debt, which is crucial to financing operations for the majority of companies, comes at a cost called interest. Interest expense has a direct bearing on the profitability of a company.

VRTX : 231.92 (+6.76%)
FN : 52.72 (+9.06%)
DQ : 55.59 (+3.37%)
LITE : 74.09 (+5.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade VRTX with:

Business Summary

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs...

See More

Key Turning Points

2nd Resistance Point 242.33
1st Resistance Point 237.13
Last Price 231.92
1st Support Level 223.36
2nd Support Level 214.79

See More

52-Week High 249.85
Last Price 231.92
Fibonacci 61.8% 216.93
Fibonacci 50% 206.77
Fibonacci 38.2% 196.60
52-Week Low 163.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar